FDA Approves Brytly as First Over-the-Counter Eye Drop for Ocular Redness
The U.S. Food and Drug Administration (FDA) has approved Brytly (apraclonidine ophthalmic solution, Alcon), 0.125%, as the first non-prescription eye drop for ocular redness caused by minor irritations like dry eye or dust. It is approved for use up to twice daily for individuals 12 years and older.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.
Open NewsSnap.ai